N-Me-Thr(tBu)-OH

N-Me-Thr(tBu)-OH is a chiral, N-methylated threonine derivative in which the side-chain hydroxyl is protected as a tert-butyl ether while the carboxylic acid remains present for downstream coupling chemistry. The molecule contains a stereogenic center at the threonine alpha-carbon, enabling stereochemically defined peptide bond formation and controlled incorporation into peptide-like scaffolds. The N-methyl functionality reduces the availability of the amide nitrogen for hydrogen-bonding and can influence conformational preferences in peptidomimetics and enzyme-binding studies. The tert-butyl-protected side-chain oxygen provides orthogonal protection that can be removed under acid-mediated conditions to reveal a primary alcohol handle for further derivatization.

1. Peptide Synthesis

N-Me-Thr(tBu)-OH serves as a protected, chiral amino acid building block for peptide coupling chemistry where threonine side-chain protection is required to prevent undesired O-acylation or side reactions. The carboxylic acid group participates in standard peptide bond formation after activation, while the N-methylated amine supports incorporation of N-methylated residues that modulate backbone hydrogen-bonding patterns. The tert-butyl ether on the side-chain hydroxyl maintains orthogonality during coupling and subsequent transformations, allowing selective deprotection later for phosphorylation-mimic synthesis or side-chain functionalization. Stereochemical integrity at the alpha-carbon supports the construction of defined peptide analogs for structure-function studies and synthetic library generation.

2. Peptidomimetics And SAR Studies

N-Me-Thr(tBu)-OH is suitable for peptidomimetic and SAR-focused medicinal chemistry workflows where N-methylated threonine residues are used to tune conformational landscapes and receptor/target binding interactions. The N-methyl group can alter amide planarity and intramolecular hydrogen bonding propensity, while the tert-butyl-protected hydroxyl preserves the side-chain oxygen during scaffold assembly. Controlled deprotection can generate a free threonine alcohol for installation of substituents such as ether-linked groups, carbonate derivatives, or handles for further conjugation. The resulting N-methylated, stereodefined amino acid residue enables systematic analog design and comparative SAR mapping through chemically consistent side-chain presentation.

3. Side-Chain Functionalization

N-Me-Thr(tBu)-OH supports side-chain derivatization strategies that begin with orthogonal protection of the threonine hydroxyl and proceed through selective unmasking. The tert-butyl ether functions as a protecting group that can be removed to reveal a primary alcohol for subsequent functional group transformations, including esterification, ether formation, or conversion to leaving-group-bearing intermediates for nucleophilic substitution. The preserved alpha-stereochemistry ensures that downstream modifications occur on a defined stereochemical framework, which is important for stereochemically sensitive structure-activity relationship studies and biomolecule recognition assays. The N-methylated backbone further enables preparation of analogs with reduced amide NH participation, supporting targeted exploration of hydrogen-bonding contributions in synthetic and biochemical systems.

4. Chemical Biology Labeling

N-Me-Thr(tBu)-OH can be applied in chemical biology workflows that require incorporation of a protected threonine residue into peptides or peptide-like probes for labeling and biomolecule interaction studies. The carboxylic acid and N-methylated amine facilitate assembly into defined probe backbones, while the tert-butyl-protected hydroxyl allows staged introduction of reactive groups after conjugation-compatible steps. Deprotection of the side-chain alcohol can enable attachment of fluorophores, affinity tags, or bioorthogonal handles through controlled derivatization chemistry. Stereodefined residue incorporation helps maintain consistent probe geometry, which is relevant for interpreting binding, uptake, or interaction readouts in mechanistic experiments.

5. Pharmaceutical Intermediate Preparation

N-Me-Thr(tBu)-OH is suitable as a chiral intermediate for manufacturing routes that produce N-methylated threonine-containing intermediates used in peptide-based drug candidates and related fine chemicals. The orthogonal protection pattern, with a tert-butyl ether on the side-chain hydroxyl and a free carboxylic acid for activation, supports scalable process design for sequential coupling and later functional-group unmasking. The N-methylated amine can be carried through synthetic sequences to furnish N-methylated amide motifs that are commonly encountered in peptide analogs and constrained backbone designs. Downstream conversion of the side-chain alcohol after deprotection can generate additional intermediate families for formulation-relevant salts, conjugates, or further derivatized building blocks used in specialty chemical production.

1. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

2. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

4. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

5. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment